Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (51-60 of 939) with videos related to

Pageof 94
Sort By:
Urologic Oncology|September 11, 2007
Therapeutic options for hormone-refractory prostate cancer in 2007Boris A Hadaschik, Martin E Gleave
British Journal of Neurosurgery|October 23, 2002
Cauda equina syndrome: what is the relationship between timing of surgery and outcome?J R W Gleave, R Macfarlane
The Journal of Family Planning and Reproductive Health Care|November 30, 2002
Evaluation of near patient testing for Chlamydia trachomatis in a pregnancy termination serviceJ Hopwood, H Mallinson, T Gleave
Cancer Research|November 4, 2000
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cellsM D Sadar, M E Gleave
Expert Opinion on Biological Therapy|June 4, 2004
Antisense approaches in prostate cancerKim N Chi, Martin E Gleave
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Good servants, poor mastersLouis-Olivier Gagnon, Martin E Gleave
Asian Journal of Andrology|April 16, 2013
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancerPaul J Toren, Martin E Gleave
International Journal of Radiation Oncology, Biology, Physics|January 15, 1993
Unnecessary morbidity following irradiation of lateralized head and neck carcinomaN J Slevin, E N Gleave
EMBO Molecular Medicine|April 22, 2015
Targeting the adaptive molecular landscape of castration-resistant prostate cancerAlexander W Wyatt, Martin E Gleave
Nature Reviews. Cancer|May 21, 2005
Antisense therapy for cancerMartin E Gleave, Brett P Monia
Pageof 94

Showing results (51-60 of 939) with videos related to

Sort By:
Pageof 94
Urologic Oncology|September 11, 2007
Therapeutic options for hormone-refractory prostate cancer in 2007Boris A Hadaschik, Martin E Gleave
British Journal of Neurosurgery|October 23, 2002
Cauda equina syndrome: what is the relationship between timing of surgery and outcome?J R W Gleave, R Macfarlane
The Journal of Family Planning and Reproductive Health Care|November 30, 2002
Evaluation of near patient testing for Chlamydia trachomatis in a pregnancy termination serviceJ Hopwood, H Mallinson, T Gleave
Cancer Research|November 4, 2000
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cellsM D Sadar, M E Gleave
Expert Opinion on Biological Therapy|June 4, 2004
Antisense approaches in prostate cancerKim N Chi, Martin E Gleave
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Good servants, poor mastersLouis-Olivier Gagnon, Martin E Gleave
Asian Journal of Andrology|April 16, 2013
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancerPaul J Toren, Martin E Gleave
International Journal of Radiation Oncology, Biology, Physics|January 15, 1993
Unnecessary morbidity following irradiation of lateralized head and neck carcinomaN J Slevin, E N Gleave
EMBO Molecular Medicine|April 22, 2015
Targeting the adaptive molecular landscape of castration-resistant prostate cancerAlexander W Wyatt, Martin E Gleave
Nature Reviews. Cancer|May 21, 2005
Antisense therapy for cancerMartin E Gleave, Brett P Monia
Pageof 94